ASHLEY FARRIS: Open Payments
NPI 1881471571 · ELIZABETH, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $56 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $51 |
| Novo Nordisk Inc | 2 | $31 |
| ABBVIE INC. | 2 | $31 |
| Lilly USA, LLC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: Auvelity, VRAYLAR, ZEPBOUND, Wegovy, Qelbree, Ozempic.
Industry payments across LA — which companies pay providers there.
